Literature DB >> 6236822

Mechanism of action of hydralazine on vascular smooth muscle.

M Jacobs.   

Abstract

Myofibrils prepared from bovine carotid arteries were used to investigate the hypotensive action of hydralazine. These myofibrils contained an ATPase and Protein Kinase which was half-maximally activated by 1 microM Ca2+. Hydralazine inhibited Ca2+ dependent ATPase and phosphorylation. Half maximal inhibition occurred at 2 X 10(-5) M hydralazine. This inhibition was accounted for by a specific reduction in the phosphorylation of a protein which migrated with the myosin P-light chains (Mr, 20,000). Phosphorylation of the latter protein is generally thought to be obligatory for muscle contraction. Thus an inhibition of this phosphorylation by hydralazine in vivo is likely to contribute to the hypotensive action of the drug.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6236822     DOI: 10.1016/0006-2952(84)90216-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

Review 1.  Drug treatment of hypertensive crisis in children.

Authors:  Christopher A Thomas
Journal:  Paediatr Drugs       Date:  2011-10-01       Impact factor: 3.022

2.  Calcium-force coupling mechanisms during vasodilator-induced relaxation of ferret aorta.

Authors:  T T DeFeo; K G Morgan
Journal:  J Physiol       Date:  1989-05       Impact factor: 5.182

3.  Hydralazine target: from blood vessels to the epigenome.

Authors:  Claudia Arce; Blanca Segura-Pacheco; Enrique Perez-Cardenas; Lucia Taja-Chayeb; Myrna Candelaria; Alfonso Dueñnas-Gonzalez
Journal:  J Transl Med       Date:  2006-02-28       Impact factor: 5.531

Review 4.  The prince and the pauper. A tale of anticancer targeted agents.

Authors:  Alfonso Dueñas-González; Patricia García-López; Luis Alonso Herrera; Jose Luis Medina-Franco; Aurora González-Fierro; Myrna Candelaria
Journal:  Mol Cancer       Date:  2008-10-23       Impact factor: 27.401

Review 5.  Patients Stratification Strategies to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson's Disease.

Authors:  Anna Masato; Michele Sandre; Angelo Antonini; Luigi Bubacco
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.